117 related articles for article (PubMed ID: 31048071)
21. Genomic Copy Number Signatures Uncovered a Genetically Distinct Group from Adenocarcinoma and Squamous Cell Carcinoma in Non-Small Cell Lung Cancer.
Lee E; Moon JW; Wang X; Kim C; Li S; Shin BK; Jung W; Kim HK; Kim HK; Lee JY
Hum Pathol; 2015 Aug; 46(8):1111-20. PubMed ID: 26003479
[TBL] [Abstract][Full Text] [Related]
22. STXBP4 Drives Tumor Growth and Is Associated with Poor Prognosis through PDGF Receptor Signaling in Lung Squamous Cell Carcinoma.
Otaka Y; Rokudai S; Kaira K; Fujieda M; Horikoshi I; Iwakawa-Kawabata R; Yoshiyama S; Yokobori T; Ohtaki Y; Shimizu K; Oyama T; Tamura J; Prives C; Nishiyama M
Clin Cancer Res; 2017 Jul; 23(13):3442-3452. PubMed ID: 28087642
[No Abstract] [Full Text] [Related]
23. 5 protein-based signature for resectable lung squamous cell carcinoma improves the prognostic performance of the TNM staging.
Martínez-Terroba E; Behrens C; Agorreta J; Monsó E; Millares L; Felip E; Rosell R; Ramirez JL; Remirez A; Torre W; Gil-Bazo I; Idoate MA; de-Torres JP; Pio R; Wistuba II; Pajares MJ; Montuenga LM
Thorax; 2019 Apr; 74(4):371-379. PubMed ID: 30472670
[TBL] [Abstract][Full Text] [Related]
24. FAM83B is a novel biomarker for diagnosis and prognosis of lung squamous cell carcinoma.
Okabe N; Ezaki J; Yamaura T; Muto S; Osugi J; Tamura H; Imai J; Ito E; Yanagisawa Y; Honma R; Gotoh M; Watanabe S; Waguri S; Suzuki H
Int J Oncol; 2015 Mar; 46(3):999-1006. PubMed ID: 25586059
[TBL] [Abstract][Full Text] [Related]
25. Prognostic biomarker study in pathologically staged N1 non-small cell lung cancer.
Komaki R; Milas L; Ro JY; Fujii T; Perkins P; Allen P; Sikes CR; Mountain CF; Ordonez NG
Int J Radiat Oncol Biol Phys; 1998 Mar; 40(4):787-96. PubMed ID: 9531362
[TBL] [Abstract][Full Text] [Related]
26. MicroRNA classifiers for predicting prognosis of squamous cell lung cancer.
Raponi M; Dossey L; Jatkoe T; Wu X; Chen G; Fan H; Beer DG
Cancer Res; 2009 Jul; 69(14):5776-83. PubMed ID: 19584273
[TBL] [Abstract][Full Text] [Related]
27. Assessment of molecular events in squamous and non-squamous cell lung carcinoma.
Yakut T; Schulten HJ; Demir A; Frank D; Danner B; Egeli U; Gebitekin C; Kahler E; Gunawan B; Urer N; Oztürk H; Füzesi L
Lung Cancer; 2006 Dec; 54(3):293-301. PubMed ID: 17011066
[TBL] [Abstract][Full Text] [Related]
28. The Different Effect of VEGF Polymorphisms on the Prognosis of Non-Small Cell Lung Cancer according to Tumor Histology.
Lee S; Kang HG; Choi JE; Lee JH; Kang HJ; Baek SA; Lee E; Seok Y; Lee WK; Lee SY; Yoo SS; Lee J; Cha SI; Kim CH; Cho S; Park JY
J Korean Med Sci; 2016 Nov; 31(11):1735-1741. PubMed ID: 27709850
[TBL] [Abstract][Full Text] [Related]
29. Dual-strand tumor-suppressor microRNA-145 (miR-145-5p and miR-145-3p) coordinately targeted MTDH in lung squamous cell carcinoma.
Mataki H; Seki N; Mizuno K; Nohata N; Kamikawaji K; Kumamoto T; Koshizuka K; Goto Y; Inoue H
Oncotarget; 2016 Nov; 7(44):72084-72098. PubMed ID: 27765924
[TBL] [Abstract][Full Text] [Related]
30. Prognostic Role of the FGFR4-388Arg Variant in Lung Squamous-Cell Carcinoma Patients With Lymph Node Involvement.
Quintanal-Villalonga Á; Carranza-Carranza A; Meléndez R; Ferrer I; Molina-Pinelo S; Paz-Ares L
Clin Lung Cancer; 2017 Nov; 18(6):667-674.e1. PubMed ID: 28583379
[TBL] [Abstract][Full Text] [Related]
31. Prognostic value of chromosomal imbalances in squamous cell carcinoma and adenocarcinoma of the lung.
Danner BC; Hellms T; Jung K; Gunawan B; Didilis V; Füzesi L; Schöndube FA
Ann Thorac Surg; 2011 Sep; 92(3):1038-43. PubMed ID: 21871296
[TBL] [Abstract][Full Text] [Related]
32. Improve Glioblastoma Multiforme Prognosis Prediction by Using Feature Selection and Multiple Kernel Learning.
Zhang Y; Li A; Peng C; Wang M
IEEE/ACM Trans Comput Biol Bioinform; 2016; 13(5):825-835. PubMed ID: 27071189
[TBL] [Abstract][Full Text] [Related]
33. Pathway aggregation for survival prediction via multiple kernel learning.
Sinnott JA; Cai T
Stat Med; 2018 Jul; 37(16):2501-2515. PubMed ID: 29664143
[TBL] [Abstract][Full Text] [Related]
34. Overexpression of SOX2 Is Associated with Better Overall Survival in Squamous Cell Lung Cancer Patients Treated with Adjuvant Radiotherapy.
Yoon HI; Park KH; Lee EJ; Keum KC; Lee CG; Kim CH; Kim YB
Cancer Res Treat; 2016 Apr; 48(2):473-82. PubMed ID: 26323639
[TBL] [Abstract][Full Text] [Related]
35. Deep Integrative Analysis for Survival Prediction.
Huang C; Zhang A; Xiao G
Pac Symp Biocomput; 2018; 23():343-352. PubMed ID: 29218895
[TBL] [Abstract][Full Text] [Related]
36. Regulation of TPD52 by antitumor microRNA-218 suppresses cancer cell migration and invasion in lung squamous cell carcinoma.
Kumamoto T; Seki N; Mataki H; Mizuno K; Kamikawaji K; Samukawa T; Koshizuka K; Goto Y; Inoue H
Int J Oncol; 2016 Nov; 49(5):1870-1880. PubMed ID: 27633630
[TBL] [Abstract][Full Text] [Related]
37. A qualitative transcriptional signature for the histological reclassification of lung squamous cell carcinomas and adenocarcinomas.
Li X; Shi G; Chu Q; Jiang W; Liu Y; Zhang S; Zhang Z; Wei Z; He F; Guo Z; Qi L
BMC Genomics; 2019 Nov; 20(1):881. PubMed ID: 31752667
[TBL] [Abstract][Full Text] [Related]
38. Gene expression signatures for predicting prognosis of squamous cell and adenocarcinomas of the lung.
Raponi M; Zhang Y; Yu J; Chen G; Lee G; Taylor JM; Macdonald J; Thomas D; Moskaluk C; Wang Y; Beer DG
Cancer Res; 2006 Aug; 66(15):7466-72. PubMed ID: 16885343
[TBL] [Abstract][Full Text] [Related]
39. Fast and interpretable genomic data analysis using multiple approximate kernel learning.
Bektaş AB; Ak Ç; Gönen M
Bioinformatics; 2022 Jun; 38(Suppl 1):i77-i83. PubMed ID: 35758810
[TBL] [Abstract][Full Text] [Related]
40. Expression of phosphatase and tensin homolog and programmed cell death ligand 1 in adenosquamous carcinoma of the lung.
Hlaing AM; Furusato B; Udo E; Kitamura Y; Souda M; Masutani M; Fukuoka J
Biochem Biophys Res Commun; 2018 Sep; 503(4):2764-2769. PubMed ID: 30100056
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
